Author Archives: health

The Latest: 10% of Washington town positive for COVID-19

REPUBLIC, Wash. — About 10% of the population of Republic, a small city in north-central Washington, has tested positive for COVID-19 in an outbreak traced to large indoor events last month at the local Fraternal Order of Eagles hall. Ferry County Memorial Hospital officials have confirmed more than 100 cases, with one reported death, since… Read More: The Latest: 10% of Washington town positive for COVID-19 »

Pre-pandemic, more than half of hospitals nab above-average Leapfrog safety grades

Dive Brief: One-third of the nation’s hospitals received A grades for the quality of care they provide, according to the Leapfrog Group’s annual survey, which graded more than 2,700 acute care facilities nationwide. Another 24% received B grades, suggesting that the nation’s hospitals are generally performing well in terms of the quality and safety of… Read More: Pre-pandemic, more than half of hospitals nab above-average Leapfrog safety… »

Mental Health Services Wane as Insurers Appear to Skirt Parity Rules During Pandemic

Therapists and other behavioral health care providers cut hours, reduced staffs and turned away patients during the pandemic as more Americans experienced depression symptoms and drug overdoses, according to a new report from the Government Accountability Office. The report on patient access to behavioral health care during the covid-19 crisis also casts doubt on whether… Read More: Mental Health Services Wane as Insurers Appear to Skirt Parity… »

FDA Approves Zynlonta (loncastuximab tesirine-lpyl) for Relapsed or Refractory Diffuse Large B-Cell Lymphoma

FDA Approves Zynlonta (loncastuximab tesirine-lpyl) for Relapsed or Refractory Diffuse Large B-Cell Lymphoma LAUSANNE, Switzerland–(BUSINESS WIRE) APRIL 23, 2021 — ADC Therapeutics SA (NYSE: ADCT) today announced that the U.S. Food and Drug Administration (FDA) has approved Zynlonta (loncastuximab tesirine-lpyl) for the treatment of adult patients with relapsed or refractory (r/r) large B-cell lymphoma after… Read More: FDA Approves Zynlonta (loncastuximab tesirine-lpyl) for Relapsed or Refractory Diffuse… »